Cargando…

Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells

Detalles Bibliográficos
Autores principales: Xiong, Zhengfang, Li, Bing, Wang, Wenjuan, Zeng, Xianghui, Li, Binye, Jian, Shengyan, Wang, Liyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936696/
https://www.ncbi.nlm.nih.gov/pubmed/36797762
http://dx.doi.org/10.1186/s13048-023-01118-0
_version_ 1784890282976739328
author Xiong, Zhengfang
Li, Bing
Wang, Wenjuan
Zeng, Xianghui
Li, Binye
Jian, Shengyan
Wang, Liyun
author_facet Xiong, Zhengfang
Li, Bing
Wang, Wenjuan
Zeng, Xianghui
Li, Binye
Jian, Shengyan
Wang, Liyun
author_sort Xiong, Zhengfang
collection PubMed
description
format Online
Article
Text
id pubmed-9936696
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99366962023-02-18 Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells Xiong, Zhengfang Li, Bing Wang, Wenjuan Zeng, Xianghui Li, Binye Jian, Shengyan Wang, Liyun J Ovarian Res Retraction Note BioMed Central 2023-02-16 /pmc/articles/PMC9936696/ /pubmed/36797762 http://dx.doi.org/10.1186/s13048-023-01118-0 Text en © BioMed Central 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Xiong, Zhengfang
Li, Bing
Wang, Wenjuan
Zeng, Xianghui
Li, Binye
Jian, Shengyan
Wang, Liyun
Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells
title Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells
title_full Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells
title_fullStr Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells
title_full_unstemmed Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells
title_short Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells
title_sort retraction note: mir-140 targets rap2a to enable the proliferation of insulin-treated ovarian granulosa cells
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936696/
https://www.ncbi.nlm.nih.gov/pubmed/36797762
http://dx.doi.org/10.1186/s13048-023-01118-0
work_keys_str_mv AT xiongzhengfang retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells
AT libing retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells
AT wangwenjuan retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells
AT zengxianghui retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells
AT libinye retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells
AT jianshengyan retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells
AT wangliyun retractionnotemir140targetsrap2atoenabletheproliferationofinsulintreatedovariangranulosacells